Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.

Salah-Eddin Al-Batran; Ralf-Dieter Hofheinz; Alexander Reichart; Claudia Pauligk; Caroline Schönherr; Rudolf Schlag; Gabriele Siegler; Steffen Dörfel; Michael Koenigsmann; Mark-Oliver Zahn; Jörg Schubert; Ali Aldaoud; Heinz-Gert Höffkes; Holger Schulz; Lars Hahn; Jens Uhlig; Wolfgang Blau; Martina Stauch; Jörg Weniger; Martin Wolf; Lutz Jacobasch; Stephan Bildat; Jürgen Wehmeyer; Nils Homann; Jörg Trojan; Oliver Waidmann; Thomas Fietz; Hans-Peter Feustel; Matthias Groschek; Jan Wierecky; Karin Waibel; Stefan Mahlmann; Uwe Schwindel; Uwe Peters; Gunter Schuch; Daniel Pink; Henning Eschenburg; Marcus-A Wörns; Hans-Detlev Harich; Ludwig Fischer von Weikersthal; Klaus-Ulrich Däßler; Dirk M Behringer; Helmut Messmann; Albrecht Kretzschmar; Eike Gallmeier; Helmut Forstbauer; Volker Kunzmann; Jens Papke; Petra Büchner-Steudel; Ursula Vehling-Kaiser; Christoph Springfeld; Arndt Vogel; Thomas J Ettrich; Marina Schaaf; Gerrit Zur Hausen; Thorsten Oliver Götze

doi:10.1002/ijc.33336

Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.

Salah-Eddin Al-Batran, Ralf-Dieter Hofheinz, Alexander Reichart, Claudia Pauligk, Caroline Schönherr, Rudolf Schlag, Gabriele Siegler (Co-author), Steffen Dörfel, Michael Koenigsmann, Mark-Oliver Zahn, Jörg Schubert, Ali Aldaoud, Heinz-Gert Höffkes, Holger Schulz, Lars Hahn, Jens Uhlig, Wolfgang Blau, Martina Stauch, Jörg Weniger, Martin WolfLutz Jacobasch, Stephan Bildat, Jürgen Wehmeyer, Nils Homann, Jörg Trojan, Oliver Waidmann, Thomas Fietz, Hans-Peter Feustel, Matthias Groschek, Jan Wierecky, Karin Waibel, Stefan Mahlmann, Uwe Schwindel, Uwe Peters, Gunter Schuch, Daniel Pink, Henning Eschenburg, Marcus-A Wörns, Hans-Detlev Harich, Ludwig Fischer von Weikersthal, Klaus-Ulrich Däßler, Dirk M Behringer, Helmut Messmann, Albrecht Kretzschmar, Eike Gallmeier, Helmut Forstbauer, Volker Kunzmann, Jens Papke, Petra Büchner-Steudel, Ursula Vehling-Kaiser, Christoph Springfeld, Arndt Vogel, Thomas J Ettrich, Marina Schaaf, Gerrit Zur Hausen, Thorsten Oliver Götze

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

11 Citations (Web of Science)

Original language	English
Pages (from-to)	1478-1488
Journal	INTERNATIONAL JOURNAL OF CANCER
Volume	148
Issue number	6
DOIs	https://doi.org/10.1002/ijc.33336
Publication status	Published - 2021

Keywords

PLUS GEMCITABINE
SURVIVAL
FOLFIRINOX
IMPACT
THERAPY
MPACT

Access to Document

10.1002/ijc.33336

Cite this

Al-Batran, S.-E., Hofheinz, R.-D., Reichart, A., Pauligk, C., Schönherr, C., Schlag, R., Siegler, G., Dörfel, S., Koenigsmann, M., Zahn, M.-O., Schubert, J., Aldaoud, A., Höffkes, H.-G., Schulz, H., Hahn, L., Uhlig, J., Blau, W., Stauch, M., Weniger, J., ... Götze, T. O. (2021). Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. INTERNATIONAL JOURNAL OF CANCER, 148(6), 1478-1488. https://doi.org/10.1002/ijc.33336

Al-Batran, Salah-Eddin ; Hofheinz, Ralf-Dieter ; Reichart, Alexander et al. / Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. In: INTERNATIONAL JOURNAL OF CANCER. 2021 ; Vol. 148, No. 6. pp. 1478-1488.

@article{dc84cfb44f6a4148b31a8eaf91e7da6c,

title = "Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.",

keywords = "PLUS GEMCITABINE, SURVIVAL, FOLFIRINOX, IMPACT, THERAPY, MPACT",

author = "Salah-Eddin Al-Batran and Ralf-Dieter Hofheinz and Alexander Reichart and Claudia Pauligk and Caroline Sch{\"o}nherr and Rudolf Schlag and Gabriele Siegler and Steffen D{\"o}rfel and Michael Koenigsmann and Mark-Oliver Zahn and J{\"o}rg Schubert and Ali Aldaoud and Heinz-Gert H{\"o}ffkes and Holger Schulz and Lars Hahn and Jens Uhlig and Wolfgang Blau and Martina Stauch and J{\"o}rg Weniger and Martin Wolf and Lutz Jacobasch and Stephan Bildat and J{\"u}rgen Wehmeyer and Nils Homann and J{\"o}rg Trojan and Oliver Waidmann and Thomas Fietz and Hans-Peter Feustel and Matthias Groschek and Jan Wierecky and Karin Waibel and Stefan Mahlmann and Uwe Schwindel and Uwe Peters and Gunter Schuch and Daniel Pink and Henning Eschenburg and Marcus-A W{\"o}rns and Hans-Detlev Harich and {von Weikersthal}, {Ludwig Fischer} and Klaus-Ulrich D{\"a}{\ss}ler and Behringer, {Dirk M} and Helmut Messmann and Albrecht Kretzschmar and Eike Gallmeier and Helmut Forstbauer and Volker Kunzmann and Jens Papke and Petra B{\"u}chner-Steudel and Ursula Vehling-Kaiser and Christoph Springfeld and Arndt Vogel and Ettrich, {Thomas J} and Marina Schaaf and Hausen, {Gerrit Zur} and G{\"o}tze, {Thorsten Oliver}",

note = "Siegler: Klinikum N{\"u}rnberg PMU, N{\"u}rnberg, Germany",

year = "2021",

doi = "10.1002/ijc.33336",

language = "English",

volume = "148",

pages = "1478--1488",

journal = "INTERNATIONAL JOURNAL OF CANCER",

issn = "0020-7136",

publisher = "Wiley Verlag ",

number = "6",

}

Al-Batran, S-E, Hofheinz, R-D, Reichart, A, Pauligk, C, Schönherr, C, Schlag, R, Siegler, G, Dörfel, S, Koenigsmann, M, Zahn, M-O, Schubert, J, Aldaoud, A, Höffkes, H-G, Schulz, H, Hahn, L, Uhlig, J, Blau, W, Stauch, M, Weniger, J, Wolf, M, Jacobasch, L, Bildat, S, Wehmeyer, J, Homann, N, Trojan, J, Waidmann, O, Fietz, T, Feustel, H-P, Groschek, M, Wierecky, J, Waibel, K, Mahlmann, S, Schwindel, U, Peters, U, Schuch, G, Pink, D, Eschenburg, H, Wörns, M-A, Harich, H-D, von Weikersthal, LF, Däßler, K-U, Behringer, DM, Messmann, H, Kretzschmar, A, Gallmeier, E, Forstbauer, H, Kunzmann, V, Papke, J, Büchner-Steudel, P, Vehling-Kaiser, U, Springfeld, C, Vogel, A, Ettrich, TJ, Schaaf, M, Hausen, GZ & Götze, TO 2021, 'Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.', INTERNATIONAL JOURNAL OF CANCER, vol. 148, no. 6, pp. 1478-1488. https://doi.org/10.1002/ijc.33336

Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. / Al-Batran, Salah-Eddin; Hofheinz, Ralf-Dieter; Reichart, Alexander et al.
In: INTERNATIONAL JOURNAL OF CANCER, Vol. 148, No. 6, 2021, p. 1478-1488.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.

AU - Al-Batran, Salah-Eddin

AU - Hofheinz, Ralf-Dieter

AU - Reichart, Alexander

AU - Pauligk, Claudia

AU - Schönherr, Caroline

AU - Schlag, Rudolf

AU - Siegler, Gabriele

AU - Dörfel, Steffen

AU - Koenigsmann, Michael

AU - Zahn, Mark-Oliver

AU - Schubert, Jörg

AU - Aldaoud, Ali

AU - Höffkes, Heinz-Gert

AU - Schulz, Holger

AU - Hahn, Lars

AU - Uhlig, Jens

AU - Blau, Wolfgang

AU - Stauch, Martina

AU - Weniger, Jörg

AU - Wolf, Martin

AU - Jacobasch, Lutz

AU - Bildat, Stephan

AU - Wehmeyer, Jürgen

AU - Homann, Nils

AU - Trojan, Jörg

AU - Waidmann, Oliver

AU - Fietz, Thomas

AU - Feustel, Hans-Peter

AU - Groschek, Matthias

AU - Wierecky, Jan

AU - Waibel, Karin

AU - Mahlmann, Stefan

AU - Schwindel, Uwe

AU - Peters, Uwe

AU - Schuch, Gunter

AU - Pink, Daniel

AU - Eschenburg, Henning

AU - Wörns, Marcus-A

AU - Harich, Hans-Detlev

AU - von Weikersthal, Ludwig Fischer

AU - Däßler, Klaus-Ulrich

AU - Behringer, Dirk M

AU - Messmann, Helmut

AU - Kretzschmar, Albrecht

AU - Gallmeier, Eike

AU - Forstbauer, Helmut

AU - Kunzmann, Volker

AU - Papke, Jens

AU - Büchner-Steudel, Petra

AU - Vehling-Kaiser, Ursula

AU - Springfeld, Christoph

AU - Vogel, Arndt

AU - Ettrich, Thomas J

AU - Schaaf, Marina

AU - Hausen, Gerrit Zur

AU - Götze, Thorsten Oliver

N1 - Siegler: Klinikum Nürnberg PMU, Nürnberg, Germany

PY - 2021

Y1 - 2021

KW - PLUS GEMCITABINE

KW - SURVIVAL

KW - FOLFIRINOX

KW - IMPACT

KW - THERAPY

KW - MPACT

U2 - 10.1002/ijc.33336

DO - 10.1002/ijc.33336

M3 - Original Article

C2 - 33038277

SN - 0020-7136

VL - 148

SP - 1478

EP - 1488

JO - INTERNATIONAL JOURNAL OF CANCER

JF - INTERNATIONAL JOURNAL OF CANCER

IS - 6

ER -

Al-Batran SE, Hofheinz RD, Reichart A, Pauligk C, Schönherr C, Schlag R et al. Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. INTERNATIONAL JOURNAL OF CANCER. 2021;148(6):1478-1488. doi: 10.1002/ijc.33336